According to a new report, published by KBV research, The Global Neurocognitive Assessment And Rehabilitation Market size is expected to reach $23.6 billion by 2030, rising at a market growth of 8.4% CAGR during the forecast period.
The Neurorehabilitation Therapy segment led the Global Neurocognitive Assessment And Rehabilitation Market by Component in 2022; thereby, achieving a market value of $15.3 Billion by 2030. Neurorehabilitation therapy focuses on enhancing functional abilities like movement, coordination, balance, and mobility. Therapeutic exercises and interventions target specific neurological impairments, promoting improvements in day-to-day activities and independence. Many neurological conditions can impact balance and coordination. Neurorehabilitation therapy includes exercises and interventions focused on improving proprioception, balance, and coordination, reducing the risk of falls, and enhancing overall stability.
The Rehab Centers segment is growing at a CAGR of 7.7 % during the forecast period. Neurocognitive assessments in rehab centers help customize rehabilitation plans by identifying cognitive strengths & challenges. This enhances the effectiveness of interventions for individuals recovering from neurological injuries or surgeries. Regular neurocognitive testing allows healthcare professionals in rehabilitation centers to monitor cognitive function changes over recovery. Rehab centers often collaborate with community resources to promote a smooth change in daily life. This may involve connecting individuals with community support services, vocational rehabilitation, and other resources contributing to long-term well-being.
The North America region dominated the Global Neurocognitive Assessment And Rehabilitation Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $7.9 Billion by 2030. The Europe region is anticipated to grow at a CAGR of 8% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 9.2% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/neurocognitive-assessment-and-rehabilitation-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH
By Component
By Providers
By Geography
Companies Profiled
Unique Offerings 
